Clinical Trials Sponsored by Bioview, Inc

Total 35396 results

Bioview, Inc.

Completed

Diagnostic Study for Lung Cancer Detection Test

Lung Cancer

United States, Israel
BioVie Inc.

Completed

A Phase 3 Study of NE3107 in Probable Alzheimer's Disease

Alzheimer Disease

United States
BioVie Inc.

Completed

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

Parkinson Disease

United States
BioVie Inc.

Terminated

A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites

Decompensated Cirrhosis | Ascites

United States
BioVie Inc.

Completed

Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

Cirrhosis | Ascites Hepatic

United States
BioKier Inc.

Completed

Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients

Type 2 Diabetes

United States
BioKier Inc.

Completed

Effects of BKR-017 on Insulin Resistance in Type 2 Diabetes Patients

Type 2 Diabetes

United States
Biotie Therapies Inc.

Completed

Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

Parkinson's Disease

Ukraine, Argentina, Romania, Canada, United States, Chile
Biotie Therapies Inc.

Terminated

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients (TOZ-PD)

Idiopathic Parkinson's Disease

Germany, Spain, Canada, United States, Italy, Austria, Czechia
Biotie Therapies Inc.

Completed

Study to Evaluate SYN115 in Parkinson's Disease

Parkinson's Disease

United States
IVIEW Therapeutics Inc.

Completed

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis

China
IVIEW Therapeutics Inc.

Completed

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

Adenoviral Conjunctivitis

India
Neurological Associates of West Los Angeles
BioVie Inc.

Not yet recruiting

Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury

Traumatic Brain Injury
Neurological Associates of West Los Angeles
BioVie Inc.

Completed

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Alzheimer Disease

United States
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Idiopathic Parkinson Disease

United States, Canada, United Kingdom
Biotie Therapies Inc.
Syneos Health

Completed

Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder

United States
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Abuse Potential

Canada
Biotie Therapies Inc.
Acorda Therapeutics

Terminated

Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant

Hepatic Impairment

United States
Bioven Europe

Terminated

Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients (EGF)

Carcinoma, Non-Small-Cell Lung

Philippines, Spain, United Kingdom, Malaysia, Georgia, Thailand, Germany, Bulgaria, Czechia, Poland, Romania
SiVIEW

Not yet recruiting

Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert

Eye Diseases | Ametropia

France
BioVex Limited

Completed

Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
BioVex Limited

Completed

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Melanoma

United States, United Kingdom
Bioven Europe

Terminated

A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients (NSCLC)

Carcinoma, Non-Small-Cell Lung

United Kingdom
Mayo Clinic
Juvenile Diabetes Research Foundation; BioKier Inc.

Recruiting

Butyrate Adjuvant Therapy for Type 1 Diabetes

Type1diabetes

United States
BioVex Limited
Amgen

Completed

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Melanoma

United States, United Kingdom, Canada, South Africa
Biotie Therapies Inc.
PRA Health Sciences; Tandem Labs; Xceleron Inc

Completed

Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant

N/A, as Healthy Volunteers

Netherlands
BioVex Limited
Covance

Completed

An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)

Melanoma
Bioven Sdn. Bhd.

Terminated

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV (NSCLC)

Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV

Malaysia
Biotie Therapies Corp.

Completed

BTT1023 in Psoriasis

Plaque Psoriasis

Germany
BioVex Limited
Amgen

Terminated

Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma

United States, United Kingdom
Biotie Therapies Corp.

Completed

BTT-1023 in Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Biotie Therapies Corp.

Completed

Safety and Pharmacokinetics of ELB353 in Healthy Men

Healthy Volunteers

Germany
Biotie Therapies Inc.
National Institute on Drug Abuse (NIDA)

Completed

Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

Cocaine Dependence

United States
Biovil Research Group, LLC

Unknown

Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

Non Alcoholic Fatty Liver Disease

United States
Washington University School of Medicine
Biovica

Recruiting

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Breast Cancer | Cancer of the Breast

United States
University of Primorska
Biovis d.o.o.

Completed

Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products

Coenzyme Q Deficiency

Slovenia
BioVex Limited
Symbion Research International

Completed

A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Melanoma

United Kingdom, United States
Washington University School of Medicine
Biovica

Not yet recruiting

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

Metastatic Breast Cancer | Unresectable Breast Cancer

United States
BioKier Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of BKR-013 on Average Daily Glucose Levels

Type 2 Diabetes Mellitus

United States
Instituto Oncológico Dr Rosell
MFAR; Bioven Europe

Completed

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C (EPICAL)

Carcinoma, Non-Small-Cell Lung

Spain
CEN Biotech
CEN Nutriment; Biovet Conseil; Amadeite SAS

Completed

The Effect of an Edible Algal Extract (Ulva Lactuca) on the Component of Depression in Healthy Volunteers With Anhedonia

Anhedonia in Healthy Volunteers
Biotie Therapies Inc.
Massachusetts General Hospital; Michael J. Fox Foundation for Parkinson's Research and other collaborators

Completed

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) (SYNAPSE)

Parkinson's Disease Dementia (PDD)

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
WntResearch AB
Institut Català d'Oncologia; SMS-Oncology BV; SAGA diagnostics AB; Unilabs A/S; BioVica...

Active, not recruiting

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer (NeoFox)

Colon Cancer

Spain
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States

3

Subscribe